In order to investigate this possibility, immunoprecipitation (IP) experiment was conducted in two different ERα-positive breast cancer cell lines, MCF-7 and T47D, using either anti-TCF21 or anti-ERα antibody. The gene discussed is TCF21; the disease is breast carcinoma.